The first approved domestic new crown antibody drugs are delivered to designated hospitals!

The first batch of drugs in the country in the nation's first batch of drugs in the country was successfully delivered to Shenzhen Third People's Hospital in the country. A total of 100 drugs were stored in the cold chain environment of 2-8 ° C. The first patient to use these drugs was an 82 -year -old elderly with basic disease. He was infected with Omikon mutant strains.

Anbawei's Mipidumi and Romi Siwei Mipidumi is a non-competitive new severe acute respiratory response from the new type of coronary virus pneumonia (COVID-19) patients in the new type of coronary virus pneumonia (COVID-19) patients with Tsinghua University and Tsinghua University. System syndrome virus 2 (SARS-COV-2) monoclonal neutralized antibody, which was approved by the State Drug Administration in December 2021. It was listed on commercialization in China on July 7th. It is the first approval autonomy in my country. New crown antibody drugs developed.

Previous global III clinical trial data showed that compared with placebo, Ambaleab and Romi Siwei's anti -combination therapy reduced the hospitalization and death risk of new crown outpatient patients with high risk of clinical progress by 80%. Scholars are significant.

According to Lu Hongzhou, the dean of Shenzhen Third Hospital, the survey data of many independent laboratories and the test data of the live virus and chimiric virus experiments show that Ambelli Mipide and Romi Siwei's combination therapy to the main new crown virus variable strains that have attracted much attention to the vast lotus virus virus All maintain neutrality, including B.1.1.529-BA.1, and BA.1.1 and BA.2. At present, confirming this combined therapy for further experiments on BA.4/5 and BA.2.12.1, including live virus analysis, is in progress.

This domestic new drug is currently located in Guangzhou. There are more than 1,000 people in total. According to the needs of various places and designated hospitals, they can be distributed at any time, and they can be delivered to all parts of Guangdong within 48 hours.

Guangzhou Radio and Television Full Media Reporter: Zheng Hanjing

Edit: Xu Anni

- END -